The hearing-loss market is concentrated with a few companies pulling the strings. In the sub-segment of severe to profound hearing loss, the Australian company Cochlear Ltd. is the undisputed leader with a market share of more than 60%. Between 2005 and 2024, the stock 14-bagged, generating stellar returns for shareholders. Since then, however, shares dropped 50% in just two years, culminating in a 20% washout in one day after the recent results. A bit surprising for a dominating leader operating in a stable market with rising demand. Is the stock a crystal-clear opportunity or why the deafening silence from buyers?